NATALIE FROST: Open Payments
NPI 1407479231 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$396 in 16 payments from 10 companies in 2025. Trend: 2023 $136 · 2024 $226 · 2025 $396
Food & beverage: $396
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $101 |
| Edwards Lifesciences Corporation | 1 | $56 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $47 |
| BridgeBio Pharma, Inc. | 3 | $46 |
| ABIOMED | 2 | $43 |
| Alnylam Pharmaceuticals Inc. | 2 | $34 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $23 |
| Amgen Inc. | 1 | $16 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: COREVALVE EVOLUT R, SAPIEN 3 Ultra RESILIA, LifeVest, Attruby, AMVUTTRA, JARDIANCE, Repatha, CAMZYOS.
Industry payments across MN — which companies pay providers there.
